Month: July 2024

Enlarge / Europe's first Ariane 6 rocket lifts off from a new launch pad in Kourou, French Guiana. (credit: Jody Amiet/AFP via Getty Images)

The first European Ariane 6 rocket fired off its launch pad at the edge of the Amazon rainforest and climbed into orbit Tuesday, an inaugural flight a decade in the making that restored Europe's ability to put its own large satellites into space.

The debut of the Ariane 6 rocket came almost exactly one year after Europe's previous workhorse rocket, the Ariane 5, flew for the final time. Running four years late, the Ariane 6 is set to become Europe's next flagship launcher. But delays in its development, combined with other factors, forced European governments to pay SpaceX to deliver several payloads to orbit.

With Tuesday's test flight, European space officials hope those days are behind them. The European Space Agency paid more than $4 billion to get the Ariane 6 rocket to this point, with the goal of replacing the Ariane 5 with a cheaper, more capable launcher. There are still pressing questions about Ariane 6's cost per launch, and whether the rocket will ever be able to meet its price target and compete with SpaceX and other companies on the commercial market.

Enlarge / Lina Khan, chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee at the Rayburn House Office Building on May 15, 2024, in Washington, DC. (credit: Getty | Kevin Dietsch)

Firms that serve as intermediaries to negotiate and control prescription drug access in the US "wield enormous power," largely with "extraordinarily opaque" business practices, and may be "inflating drug costs and squeezing Main Street pharmacies" for profit, according to a searing interim report released Tuesday by the Federal Trade Commission.

Amid a national focus on America's uniquely astronomical drug costs, the FTC is taking aim at firms that largely work deep in the bowels of the country's labyrinthine health care system, well hidden from public understanding and scrutiny: pharmacy benefit managers (PBMs).

PBMs were initially hired by various payors—employers, health insurance companies, government health plans, and others—to manage prescription drug benefits through various plans. But PBMs have evolved over the years to also negotiate rebates from drugmakers, set reimbursements for dispensing pharmacies, and develop drug formularies (the list of drugs that a health plan covers.) While those functions alone grant PBMs a large amount of power, consolidation and integration over recent years has concentrated that power in troubling ways, according to the FTC report.

Enlarge / A screenshot of tvOS 17. Recent betas have included evidence that Apple is working on a touchscreen-enabled version of the interface. (credit: Andrew Cunningham)

Apple’s tvOS betas are usually among its least exciting; the Apple TV’s operating system has changed so little in the last decade that the most exciting thing to happen to it in recent memory is an extra column of icons.

But this week’s tvOS 18 beta 3 release includes a hidden feature that might be exciting for smart speaker enthusiasts, if not for people who still want their Apple TV boxes to develop exciting new capabilities. 9to5Mac has discovered a touchscreen interface (codenamed "PlasterBoard") inside of the latest beta, a sign that Apple is testing alternate input mechanisms for software that is currently manipulated via remote control and voice.

Last week, MacRumors also discovered a reference to a device called “HomeAccessory17,1” in Apple’s beta software, a naming convention similar to the “AudioAccessory” device identifiers that Apple uses for HomePod speakers. Together, these developments suggest that Apple is working on a version of the HomePod with an integrated touchscreen, a device that rumors have suggested could launch in 2024 or 2025. The company has reportedly been working on a smart home device with a screen since at least 2021.